Cargando…
Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19: A Vanguard Multicenter, Rapidly Adaptive, Pragmatic, Randomized Controlled Trial
BACKGROUND: Pulmonary vascular microthrombi are a proposed mechanism of COVID-19 respiratory failure. We hypothesized that early administration of tissue plasminogen activator (tPA) followed by therapeutic heparin would improve pulmonary function in these patients. RESEARCH QUESTION: Does tPA improv...
Ejemplares similares
-
MUlticenter STudy of tissue plasminogen activator (alteplase) use in COVID‐19 severe respiratory failure (MUST COVID): A retrospective cohort study
por: Barrett, Christopher D., et al.
Publicado: (2022) -
The Vanguard
Publicado: (1888) -
Wailin' at the Vanguard
por: Taylor, Art
Publicado: (1993) -
Study of alteplase for respiratory failure in severe acute respiratory syndrome coronavirus 2/COVID‐19: Study design of the phase IIa STARS trial
por: Moore, Hunter B., et al.
Publicado: (2020) -
Vanguard management: redesigning the corporate future
por: O'Toole, James
Publicado: (1985)